Verve Therapeutics' lead experimental therapy, dubbed VERVE-101, aims to slash bad cholesterol levels and effectively cure patients with a serious genetic heart disease by editing a tiny piece of their DNA. Verve CEO and cofounder Dr. Sekar Kathiresan told Business Insider that's the first part of his three-step strategy in transforming how heart disease is treated.
Kathiresan, a prominent cardiologist, founded Verve while working as a researcher at the Broad Institute and Massachusetts General Hospital. After a lifetime of studying the heart and its related genetics, Kathiresan resigned from his positions to lead Verve, which was incubated by GV, formerly known as Google Ventures, from 2016 to 2018.
The biotech's first experimental treatment was built using tools from the biotech Beam Therapeutics called base editing technology. It's a more precise way to edit genes, allowing scientists to change a single letter of genetic code. These patients have abnormally high levels of LDL, or bad cholesterol from birth, which often result in overworked arteries. The ultimate result is young patients, often in their 30s or 40s, having heart attacks, strokes, and sometimes even dying.
Verve's partner Beam, for instance, went public in February 2020 at a valuation of more than $1 billion. Less than a year later, Beam's stock has increased more than 350%, with the biotech now worth well over $5 billion, despite having no treatments ready for testing in people. . The initial work in patients with this genetic heart condition is the first of three steps, Kathiresan said.The second phase will expand research to anybody with atherosclerotic heart disease, a group that Kathiresan estimated at about 24 million people in the US and Europe. That's a condition in which plaque builds up in arteries, narrowing them and potentially blocking blood flow or causing them to break.
Well dont forget to trash Nature mag for politically spineless aryan nationalism, meanwhile in China , one of their own most NobelPrize worthy scientists Dr He Jiankui is in prison for Xi's nearly panicked defensiveness to welcome future tech.
ประเทศไทย ข่าวล่าสุด, ประเทศไทย หัวข้อข่าว
Similar News:คุณยังสามารถอ่านข่าวที่คล้ายกันนี้ซึ่งเรารวบรวมจากแหล่งข่าวอื่น ๆ ได้
CEO of Thinx says now is the 'perfect time to expand into activewear' - Business InsiderThinx CEO reveals why now is the 'perfect time to expand into activewear' after the feminine care brand increased revenue by 48% in 2020
แหล่ง: BusinessInsider - 🏆 729. / 51 อ่านเพิ่มเติม »
MyPillow offers 'FightForTrump' discount, CEO stands by Trump - Business InsiderMyPillow's CEO is standing by Trump after the deadly Capitol riots, and offering customers a discount with the code 'FightForTrump' Hope people stop buying his pillows! He needs to be investigated if he helped fund this coup.
แหล่ง: BusinessInsider - 🏆 729. / 51 อ่านเพิ่มเติม »
Parler must up moderation for return to iPhone app store: Apple CEO - Business InsiderParler — a social media app that was used to organize the attack on the US Capitol — needs to step up moderation to get back on the iPhone, Apple CEO Tim Cook says or to make a website instead of an app, just saying...
แหล่ง: BusinessInsider - 🏆 729. / 51 อ่านเพิ่มเติม »
Goya votes to silence CEO Unanue over voter fraud claims: CNN, NYP - Business InsiderGoya Foods has voted to silence its Trump-supporting CEO Robert Unanue after he told Fox News the election was 'unverified' Good. Feed him cold beans! Pardon me, while I chuckle! I walk right by the Goya isle now lol
แหล่ง: BusinessInsider - 🏆 729. / 51 อ่านเพิ่มเติม »
Xiborg CEO reflects on how the pandemic has influenced the company's production methods - Business InsiderCEO Ken Endo outlines the new vision for Xiborg and reflects on how the pandemic has influenced the company's production methods. Presented by ING_News
แหล่ง: BusinessInsider - 🏆 729. / 51 อ่านเพิ่มเติม »